What Are The Strategic Insights Behind The In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Expansion To $23.59 Billion?
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Are The Future Growth Projections For The In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Size?
The market size of in vitro diagnostics (ivd) in cardiology and neurology has shown considerable growth in the past few years. The market is projected to expand from $15.84 billion in 2024 to $17.22 billion in 2025, witnessing a compound annual growth rate (CAGR) of 8.7%. This significant growth in the historical period is due to factors such as an increase in age-related cardiovascular and neurological disease prevalence, growing aging populace, a heightened focus on preventive healthcare and proactive disease detection. Additionally, the escalating burden of cardiovascular diseases (CVDs) and neurological conditions like stroke and Alzheimer’s disease, increased investment in healthcare infrastructure, and improved regulatory guidelines governing the approval and reimbursement of diagnostic tests have also contributed to this growth.
The market size for in vitro diagnostic (ivd) in cardiology and neurology is set to witness significant growth over the next couple of years, projected to reach $23.59 billion in 2029 at an 8.2% compound annual growth rate (CAGR). Factors contributing to this predicted growth during the forecast period include the move towards personalized medicines in both cardiology and neurology, the growing requirement for quick and convenient on-site testing options in these fields, the expansion of telemedicine as well as remote consultation services, and a surge in research initiatives. The forecast period is also expected to see key trends such as the rise of liquid biopsy technologies, progress in nanotechnology, the uptake of remote monitoring tools like implantable cardiac monitors and brain-computer interfaces, the utilization of multiplex biomarker panels, advances in medical imaging techniques, including MRI, CT, and PET scans, and the creation of companion diagnostics for drugs related to cardiovascular and neurological conditions.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15829&type=smp
Which Demand Drivers Are Strengthening The In Vitro Diagnostic (IVD) In Cardiology And Neurology Market?
The surge in bespoke healthcare, known as personalized medicine, is foreseen to stimulate the enhancement of the in vitro diagnostic (IVD) market in cardiology and neurology. Customized medicine encapsulates a healthcare tactic that customizes healthcare solutions and treatments based on each patient’s unique traits. This sector sees growth fueled by developments in genomics, a better comprehension of the disease process, patient preference for personalized treatment, and regulatory backing, among others. Tailored healthcare solutions are made possible through IVD tests in cardiology and neurology, as they offer vital insights into a patient’s genetic profile and health condition, paving the way for customized treatment plans that maximize effectiveness while minimizing risks. For instance, the Personalized Medicine Coalition, a professional collective based in the United States, stated in 2022, that 12 new bespoke medicines got the nod from regulatory authorities, accounting for about 34% of all newly-sanctioned therapies. This shows a significant rise from prior years. Thus, the escalation in the roll-out of custom-made medicines is propelling the in vitro diagnostic (IVD) market in cardiology and neurology.
What Segmentation Insights Are Provided In The In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Research?
The in vitro diagnostic (ivd) in cardiology and neurologymarket covered in this report is segmented –
1) By Product Type: Instruments; Reagents And Consumables; Software And Services
2) By Technology: Immunoassays; Molecular Diagnostics; Hematology; Other Technologies
3) By End-User: Hospitals; Clinical Laboratories; Other End-Users
Subsegments:
1) By Instruments: Diagnostic Analyzers; Point-Of-Care Devices; Electrophysiology Devices
2) By Reagents And Consumables: Diagnostic Reagents; Test Kits; Assay Consumables
3) By Software And Services: Diagnostic Software; Data Management Software; IVD Consulting And Support Services
Which Notable Trends Are Transforming The In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Outlook?
Prominent firms in the cardiology and neurology in vitro diagnostic (IVD) sector are engineering AI-integrated epigenetic engines for early ailment identification and risk evaluation. These AI-inclusive integrated epigenetic engines utilize machine-learning models and sophisticated biomarker analysis methods to improve precision and sensitivity in detecting and tracking cardiovascular illnesses while addressing fundamental triggers of disease advancement. For example, in February 2023, Cardio Diagnostics Holdings Inc., an American biotechnology company, introduced PrecisionCHD, an AI-based blood examination intended for the early diagnosis of coronary heart disease (CHD). The test, using the firm’s own inclusive epigenetic-genetic engine, evaluates CHD susceptibility and strives for the prevention and detection of the most prevalent type of cardiovascular illness. The innovative test merges epigenetic and genetic biomarkers with machine-learning algorithms, providing over 75% sensitivity for both genders. It correlates a patient’s biomarker profile with adjustable risk elements, key factors in CHD such as smoking, diabetes, hypertension, and high cholesterol levels. PrecisionCHD provides a non-intrusive substitute to exercise stress tests or angiograms, with blood samples collected either in the office or home setting.
Which Firms Are Driving Innovation Within The In Vitro Diagnostic (IVD) In Cardiology And Neurology Market?
Major companies operating in the in vitro diagnostic (IVD) in cardiology and neurology market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson And Company, Quest Diagnostics Incorporated, Hologic Inc., Illumina Inc., Beckman Coulter Inc., Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Instrumentation Laboratory, bioMérieux SA, Natera, Inc., Randox Laboratories Ltd., Fulgent Genetics Inc., DiaSorin S.p.A., Oxford Nanopore Technologies, Fujirebio Diagnostics Inc., Adaptive Biotechnologies, Biocartis Group NV, Agena Bioscience
Access The Complete Report Here:
Which Regional Markets Are Emerging As Key Hubs For The In Vitro Diagnostic (IVD) In Cardiology And Neurology Market?
North America was the largest region in the in vitro diagnostic (IVD) in cardiology and neurology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in vitro diagnostic (IVD) in cardiology and neurology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=15829&type=smp
Browse Through More Reports Similar to the Global In Vitro Diagnostic (IVD) In Cardiology And Neurology Market 2025, By The Business Research Company
In Vitro Diagnostics Ivd Quality Control Global Market Report 2025
In Vitro Toxicology Testing Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/in-vitro-toxicology-testing-global-market-report
In Vitro Diagnostics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
